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We describe the development and evaluation of a novel method for targeted amplification
and Next Generation Sequencing (NGS)-based identification of viral hemorrhagic fever
(VHF) agents and assess the feasibility of this approach in diagnostics.
Methodology
An ultrahigh-multiplex panel was designed with primers to amplify all known variants of
VHF-associated viruses and relevant controls. The performance of the panel was evaluated
via serially quantified nucleic acids from Yellow fever virus, Rift Valley fever virus, Crimean-
Congo hemorrhagic fever (CCHF) virus, Ebola virus, Junin virus and Chikungunya virus in a
semiconductor-based sequencing platform. A comparison of direct NGS and targeted
amplification-NGS was performed. The panel was further tested via a real-time nanopore
sequencing-based platform, using clinical specimens from CCHF patients.
Principal findings
The multiplex primer panel comprises two pools of 285 and 256 primer pairs for the identifi-
cation of 46 virus species causing hemorrhagic fevers, encompassing 6,130 genetic vari-
ants of the strains involved. In silico validation revealed that the panel detected over 97% of
all known genetic variants of the targeted virus species. High levels of specificity and sensi-
tivity were observed for the tested virus strains. Targeted amplification ensured viral read
detection in specimens with the lowest virus concentration (1–10 genome equivalents) and
enabled significant increases in specific reads over background for all viruses investigated.
In clinical specimens, the panel enabled detection of the causative agent and its characteri-
zation within 10 minutes of sequencing, with sample-to-result time of less than 3.5 hours.
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Conclusions
Virus enrichment via targeted amplification followed by NGS is an applicable strategy for the
diagnosis of VHFs which can be adapted for high-throughput or nanopore sequencing plat-
forms and employed for surveillance or outbreak monitoring.
Author summary
Viral hemorrhagic fever is a severe and potentially lethal disease, characterized by fever,
malaise, vomiting, mucosal and gastrointestinal bleeding, and hypotension, in which
multiple organ systems are affected. Due to modern transportation and global trade, out-
breaks of viral hemorrhagic fevers have the potential to spread rapidly and affect a signifi-
cant number of susceptible individuals. Thus, urgent and robust diagnostics with an
identification of the causative virus is crucial. However, this is challenged by the number
and diversity of the viruses associated with hemorrhagic fever. Several viruses classified in
Arenaviridae, Filoviridae, and Flaviviridae families and Bunyavirales order may cause symp-
toms of febrile disease with hemorrhagic symptoms. We have developed and evaluated a
novel method that can potentially identify all viruses and their genomic variants known to
cause hemorrhagic fever in humans. The method relies on selected amplification of the tar-
get viral nucleic acids and subsequent high throughput sequencing technology for strain
identification. Computer-based evaluations have revealed very high sensitivity and specific-
ity, provided that the primer design is kept updated. Laboratory tests using several standard
hemorrhagic virus strains and patient specimens have demonstrated excellent suitability of
the assay in various sequencing platforms, which can achieve a definitive diagnosis in less
than 3.5 hours.
Introduction
Outbreaks of viral hemorrhagic fever (VHF) occur in many parts of the world [1,2]. VHFs are
caused by various single-stranded RNA viruses, the majority of which are classified in Arena-
viridae, Filoviridae, and Flaviviridae families and Bunyavirales order [3]. Human infections
show high morbidity and mortality rates, can spread easily, and require rapid responses based
on comprehensive pathogen identification [1,3,4]. However, routine diagnostic approaches
are challenged when fast and simultaneous screening for different viral pathogens in higher
numbers of individuals is necessary [5]. Even PCR as a widely used diagnostic method, usually
providing specific virus identification, requires intense hands-on time for parallel screening of
larger quantity of specimens and provides limited genetic information about the target virus.
Multiplexing of different specific PCR assays aims at dealing with these drawbacks; however,
until recently, it was limited to a few primer pairs in one reaction due to a lack of amplicon
identification approaches for more than five targets [6,7].
Next Generation Sequencing (NGS) has provided novel options for the identification of
viruses, including simultaneous and unbiased screening for different pathogens and multiplex-
ing of various samples in a single sequencing run [8]. Furthermore, the development of real-
time sequencing platforms has enabled processing and analysis of individual specimens within
reasonable timeframes [9]. However, virus identification with NGS is also accompanied by
major drawbacks, such as diminished sensitivity when viral genome numbers in the sample
are insufficient and masked by unbiased sequencing of all nucleic acids present in the
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specimen, including the host genome [10,11]. Attempts to increase the sensitivity of NGS-
based diagnostics have focused on enrichment of virus material and libraries before sequenc-
ing, including amplicon sequencing, PCR-generated baits, and solution-based capture tech-
niques [12–14]. The strategy of ultrahigh-multiplex PCR with subsequent NGS has previously
been employed for human single nucleotide polymorphism typing, genetic variations in
human cardiomyopathies, and bacterial biothreat agents [15–17]. In this study, we describe
the development and initial evaluation of a novel method for targeted amplification and NGS-
identification of viral febrile disease and hemorrhagic fever agents and assess the feasibility of
this approach in diagnostics.
Methods
Ethics statement
The human specimens, used for the evaluation of the developed panel were obtained from
adults after written informed consent and in full compliance of the local ethics board approval
(Ankara Research and Training Hospital, 13.07.11/0426).
Panel design
Viruses reported to cause VHF as well as related strains, associated with febrile disease accom-
panied by arthritis, respiratory symptoms, or meningoencephalitis, were included in the
design to enable differential diagnosis (Table 1). For each virus strain, all genetic variants with
complete or near-complete genomes deposited in GenBank (https://www.ncbi.nlm.nih.gov/
genbank/) were assembled into groups of>90% nucleotide sequence identity via the Geneious
software (version 9.1.3) [18]. The consensus sequence of each group was included in the
design. The primer sequences were deduced using the Ion AmpliSeq Designer online tool
(https://ampliseq.com/browse.action) which provides a custom multiplex primer pool design
for NGS (Thermo Fisher Scientific, Waltham, MA). For initial evaluation of the approach and
as internal controls, human-pathogenic viruses belonging in identical and/or distinct families/
genera but not associated with hemorrhagic fever or febrile disease were included in the design
(Table 1).
In silico panel evaluation
The designed primers were tested in silico for specific binding to the target virus strains,
including all known genotypes and genetic variants. The primer sets were aligned to their spe-
cific target reference sequences and relative primer orientation, amplicon size and overlap,
and total mismatches for each primer were evaluated using the Geneious software [18]. Pairs
targeting a specific virus with less than two mismatches in sense and antisense primers were
defined as a hit and employed for sensitivity calculations. Unspecific binding of each primer to
non-viral targets was investigated via the BLASTn algorithm, implemented within the National
Center for Biotechnology Information website (https://blast.ncbi.nlm.nih.gov/Blast.cgi) [19].
The sensitivity and specificity of the primer panel for each virus were determined via standard
methods as described previously [20].
Panel evaluation via virus strains
The performance of the novel panel for the detection of major VHF agents was evaluated via
selected virus strains. For this purpose, nucleic acids from Yellow fever virus (YFV) strain
17D, Rift Valley fever virus (RVFV) strain MP-12, Crimean-Congo hemorrhagic fever virus
(CCHFV) strain UCCR4401, Zaire Ebola virus (EBOV) strain Makona-G367, Chikungunya
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Table 1. List of the viruses targeted by the ultrahigh-multiplex assay.
Family Genus Strain / Species








Nairoviridae Orthonairovirus Crimean-Congo Hemorrhagic fever virus*
Dugbe virus
Peribunyaviridae Orthobunyavirus Oropouche virus







Phenuiviridae Phlebovirus Heartland virus
Sandfly fever Sicilian virus
Severe fever with thrombocytopenia syndrome virus*
Punta Toro virus
Rift Valley fever virus*
Toscana virus
Uukuniemi virus












Kyasanur Forest disease virus*
Omsk hemorrhagic fever virus*
West Nile virus
Hepavivirus Hepatitis C virus
Hepadnaviridae Orthohepadnavirus Hepatitis B virus
Hepeviridae Orthohepevirus Hepatitis E virus
Picornaviridae Hepatovirus Hepatitis A virus
Rhabdoviridae Tibrovirus Bas-Congo virus*
(Continued )
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virus (CHIKV) strain LR2006-OPY1 and Junin mammarenavirus (JUNV) strain P3766 were
extracted with the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) with subsequent
cDNA synthesis according to the SuperScript IV Reverse Transcriptase protocol (Thermo
Fisher Scientific). Genome concentration of all strains was determined by specific quantitative
real-time PCRs using plasmid-derived virus standards, as described previously (protocols are
available upon request). Genome equivalents (ge) of 100–103 for each virus were prepared and
mixed with 10 ng of human genetic material recovered from HeLa cells.
In order to compare the efficiency of amplification with the novel panel versus direct NGS,
all virus cDNAs were further subjected to second strand cDNA synthesis using the NEBNext
RNA Second Strand Synthesis Module (New England BioLabs GmbH, Frankfurt, Germany)
according to the manufacturer’s instructions. Reagent-only mixes and HeLa cell extracts were
employed as negative controls in the experiments.
Panel evaluation via human specimens
The performance of the panel was further tested on clinical specimens from individuals with a
clinical and laboratory diagnosis of VHF [21]. For this purpose, previously stored sera with
quantifiable CCHFV RNA and lacking IgM or IgG antibodies were employed and processed
via High Pure Viral Nucleic Acid Kit (Roche, Mannheim, Germany) and the SuperScript IV
Reverse Transcriptase (Thermo Fisher Scientific) protocols, as suggested by the manufacturer.
Two human sera, without detectable nucleic acids of the targeted viral strains were tested in
parallel as negative controls.
PCR amplification
The specimens were amplified using the custom primer panels designed for HFVs with the fol-
lowing PCR conditions for each pool: 2 μl of viral cDNA mixed with human genetic material,
5 μl of primer pool, 0.5 mM dNTP (Invitrogen, Karlsruhe, Germany), 5 μl of 10 x Platinum
Taq buffer, 4 mM MgCl2, and 10 U Platinum Taq polymerase (Invitrogen) with added water
to a final volume of 25 μl. Cycling conditions were 94˚C for 7 minutes, 45 amplification cycles
at 94˚C for 20 seconds, 60˚C for 1 minute, and 72˚C for 20 seconds, and a final extension step
for 6 minutes (at 72˚C). Thermal cycling was performed in an Eppendorf Mastercycler Pro
(Eppendorf Vertrieb Deutschland, Wesseling-Berzdorf, Germany) with a total runtime of 90
minutes.
Library preparation and NGS sequencing
The amplicons obtained from the virus strains were subjected to the Ion Torrent Personal
Genome Machine (PGM) System for NGS analysis (Thermo Fisher Scientific Inc.). Initially,
Table 1. (Continued)
Family Genus Strain / Species





- Deltaviridae Hepatitis D virus
* documented as a confirmed or probable causative agent of VHF in humans
https://doi.org/10.1371/journal.pntd.0006075.t001
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the specimens were purified with an equal volume of Agencourt AMPure XP Reagent (Beck-
man Coulter, Krefeld, Germany). PGM libraries were prepared according to the Ion Xpress
Plus gDNA Fragment Library Kit, using the “Amplicon Libraries without Fragmentation” pro-
tocol (Thermo Fisher Scientific). For direct NGS, specimens were fragmented with the Ion
Shear Plus Reagents Kit (Thermo Fisher Scientific) with a reaction time of 8 minutes. Subse-
quently, libraries were prepared using the Ion Xpress Plus gDNA Fragment Library Prepara-
tion kit and associated protocol (Thermo Fisher Scientific). All libraries were quality checked
using the Agilent Bioanalyzer (Agilent Technologies, Frankfurt, Germany), quantitated with
the Ion Library Quantitation Kit (Thermo Fisher Scientific), and pooled equimolarly.
Enriched, template-positive Ion PGM Hi-Q Ion Sphere Particles were prepared using the Ion
PGM Hi-Q Template protocol with the Ion PGM Hi-Q OT2 400 Kit (Thermo Fisher Scien-
tific). Sequencing was performed with the Ion PGM Hi-Q Sequencing protocol, using a 318
chip.
Amplicons obtained from CCHFV-infected individuals and controls were processed for
nanopore sequencing via MinION (Oxford Nanopore Technologies, Oxford, United King-
dom). The libraries were prepared using the ligation sequencing kit 1D, SQK-LSK108, R9.4
(Oxford Nanopore Technologies). Subsequently, the libraries were loaded on Oxford Nano-
pore MinION SpotON Flow Cells Mk I, R9.4 (Oxford Nanopore Technologies) using the
library loading beads and run until initial viral reads were detected.
Bioinformatic analysis
The sequences generated by PGM sequencing were trimmed to remove adaptors from each
end using Trimmomatic [22], and reads shorter than 50 base pairs were discarded. All remain-
ing reads were mapped against the viral reference database prepared during the design process
via Geneious 9.1.3 software [18]. During and after MinION sequencing, all basecalled reads in
fast5 format were extracted in fasta format using Poretools software [23]. The BLASTn algo-
rithm was employed for sequence similarity searches in the public databases when required.
Results
The VHF panel and in silico performance
The AmpliSeq design for the custom multiplex primer panel resulted in two pools of 285 and
256 primer pairs for the identification of 46 virus species causing hemorrhagic fevers, encom-
passing 6,130 genetic variants of the strains involved. All amplicons were designed to be within
a range of 125–375 base pairs. Melting temperature values of the primers ranged from 55.3˚C
to 65.0˚C. No amplicons <1,000 base pairs with primer pairs in relative orientation and dis-
tance to each other could be identified, leading to an overall specificity of 100% for all virus
species. The primer sequences in the panels are provided in S1 Table.
The overall sensitivity of the panel reached 97.9%, with the primer pairs targeting 6,007 out
of 6,130 genetic variants (1 mismatch in one or both of each primers of a primer pair accepted,
as described above) (Fig 1). Impaired sensitivity was noted for Hantaan virus (0.05). Evalua-
tion of all Hantaan virus variants in GenBank revealed that newly added virus sequences were
divergent by up to 17% from sequences included in the panel design, leading to diminished
primer binding. These sequences could be fully covered by two sets of additional primers.
Comparison of direct and targeted NGS
Amplification of viral targets with the multiplex PCR panel prior to NGS resulted in a signifi-
cant increase of viral read numbers compared to direct NGS (Figs 2 and 3, S2 Table). In
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Fig 1. Sensitivity of the designed primers according to the target virus genetic variants referenced in GenBank. Total number of reference
sequences and PCR sensitivity for each virus are indicated on the y-axis. Numbers of mismatches in the primers are encoded with colours.
https://doi.org/10.1371/journal.pntd.0006075.g001
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specimens with 103 ge of the target strain, the ratio of viral reads to unspecific background
increased from 1×10−3 to 0.25 (CCHFV), 3×10−5 to 0.34 (RVFV), 1×10−4 to 0.27 (EBOV), and
2×10−5 to 0.64 (CHIKV) with fold-changes of 247, 10,297, 1,633, and 25,398, respectively. In
direct NGS, no viral reads could be detected for CCHFV and CHIKV genomic concentrations
lower than 103, and this approach failed to identify YFV and JUNV regardless of the initial
virus count. In targeted NGS, the limit of detection was noted as 100 ge for YFV, CCHFV,
RVFV, EBOV, and CHIKV and 101 ge for JUNV. For the viruses detectable via direct NGS,
amplification provided significant increases in specific viral reads over total reads ratios, from
10−4 to 0.19 (CCHFV, 1,900-fold change), 2×10−5 to 0.19 (RVFV, 9,500-fold change), and
3×10−4 to 0.56 (EBOV, 1,866-fold change). The average duration of the workflow of direct and
targeted NGS via PGM was 19 and 20.5 hours, respectively.
Patient specimen findings
In all patient sera evaluated via nanopore sequencing following amplification, the causative
agent could be detected after 1 to 9 minutes of the NGS run (Table 2). The characterized
sequences were 89–99% identical to the CCHFV strain Kelkit L segment (GenBank accession:
GQ337055) known to be in circulation in Turkey [24, 25]. No targeted viral sequence could be
observed in human sera used as negative controls during 1 hour of sequencing. The prepara-
tion, amplification, and sequencing steps of the clinical specimens could be completed with a
total sample-to-result time of less than 3.5 hours.
Fig 2. Number of virus-specific amplicons detected via semiconductor sequencing in 1 million total reads with (+) or without (-) amplification with
the novel panel (YFV: Yellow fever virus; RVFV: Rift Valley fever virus; CCHFV: Crimean-Congo hemorrhagic fever virus).
https://doi.org/10.1371/journal.pntd.0006075.g002
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Discussion
In this study, we report the development and evaluation of an ultrahigh-multiplex PCR for the
enrichment of viral targets before NGS, which aims to provide a robust molecular diagnosis in
VHFs. The panel was observed to be highly specific and sensitive and to have the capacity to
detect over 97% of all known genetic variants of the targeted 46 viral species in silico. The sensi-
tivity of the primer panel was impaired by virus sequences not included in the original design,
as noted for Hantaan virus in this study. As 36 out of a total of 59 isolates have been published
after panel design was completed, these genetic variants of Hantaan virus could not be detected
with a comparable sensitivity or not at all with the current panel. This indicates that the panel
Fig 3. Number of virus-specific amplicons detected via semiconductor sequencing in 1 million total reads with (+) or without (-) amplification with
the novel panel (EBOV: Ebola virus; CHIKV: Chikungunya virus; JUNV: Junin virus).
https://doi.org/10.1371/journal.pntd.0006075.g003
Table 2. Findings of the targeted amplification via the novel panel and real-time nanopore sequencing in patient serum specimens with CCHFV-
induced hemorrhagic fever.
# Origin Virus identified Virus load1 Viral reads Total reads Time to first viral read Processing time2
1 Turkey, Ankara CCHFV-Kelkit06 1.96 x 106 39 3860 9 min 189 min
2 Turkey, Ankara CCHFV-Kelkit06 5.20 x 107 4 1244 1 min 181 min
3 Turkey, Ankara CCHFV-Kelkit06 1.90 x 106 97 8025 1 min 181 min
1 (ge/ml)
2 includes all specimen processing steps until definitive diagnosis.
https://doi.org/10.1371/journal.pntd.0006075.t002
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has to be adapted to newly-available sequences in public databases. We have evaluated how the
panel could be updated to accommodate these recently-added sequences and observed that
two additional primer pairs could sufficiently cover all divergent entries. Although the
approach for the panel design as well as the actual design with the AmpliSeq pipeline was suc-
cessful for all genetic variants included, the amplification of viral sequences significantly
diverging from the panel could not be guaranteed, which may also apply for novel viruses.
Unlike other pathogenic microorganisms, viruses can be highly variable in their genome. Only
rarely do they share genes among all viruses or virus species that could be targeted as a virus-
generic marker by amplification. Our strategy for primer design and the AmpliSeq pipeline do
not permit the generation of degenerated primers or the targeting of very specific consensus
sequences. However, the design of the primer panel is relatively flexible, and additional primer
pairs can be appended in response to recently published virus genomes. Moreover, an updated
panel will also encompass non-viral pathogens relevant for differential diagnosis, and syn-
drome-specific panels targeting only VHF agents or virally induced febrile diseases such as
West Nile fever and Chikungunya can be developed.
We have further tested the panel using quantitated nucleic acids of six well-characterized
viruses responsible for VHF or severe febrile disease, with a background of human genetic
material to simulate specimens likely to be submitted for diagnosis, using the semiconductor
PGM sequencing platform. The impact of amplification was evaluated with a comparison of
direct and amplicon-based NGS runs. Overall, targeted amplification prior to NGS ensured
viral read detection in specimens with the lowest virus concentration (1 ge) in five of the six
viruses evaluated and 10 ge in the remaining strain, which is within the range of the established
real-time PCR assays. Furthermore, this approach enabled significant increases in specific viral
reads over background in all of the viruses, with varying fold changes in different strains and
concentrations (Figs 2 and 3). The increased sensitivity and specificity provided with the tar-
geted amplification suggest that it can be directly employed for the investigation of suspected
VHF cases where viremia is usually short and the time point of maximum virus load is often
missed [1,5].
Finally, we evaluated the VHF panel by using serum specimens obtained during the acute
phase of CCHFV-induced disease and employed an alternate NGS platform based on nano-
pore sequencing. This approach enabled virus detection and characterization within 10 min-
utes of the NGS run and can be completed in less than 3.5 hours in total (Table 2). The impact
of the nanopore sequencing has been revealed previously, during the EBOV outbreak in West
Africa where the system provided an efficient method for real-time genomic surveillance of
the causative agent in a resource-limited setting [26]. Field-forward protocols based on nano-
pore sequencing have also been developed recently for pathogen screening in arthropods [27].
Specimen processing time is likely to be further reduced via the recently developed rapid
library preparation options. While the duration of the workflow is longer, the PGM and simi-
lar platforms are well-suited for the parallel investigation of higher specimen numbers.
Although we have demonstrated in this study that targeted amplification and NGS-based
characterization of VHF and febrile disease agents is an applicable strategy for diagnosis and
surveillance, there are also limitations of this approach. In addition to the requirement of
primer sequence updates, the majority of the workflow requires non-standard equipment and
well-trained personnel, usually out of reach for the majority of laboratories in underprivileged
geographical regions mainly affected by these diseases. However, NGS technologies are
becoming widely available with reduced total costs and can be swiftly transported and set up
in temporary facilities in field conditions [26,27]. During outbreak investigations, where it is
impractical and expensive to test for several individual agents via specific PCRs, this approach
can easily provide information on the causative agent, facilitating timely implementation of
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containment and control measures. Additional validation of the approach will be provided
with the evaluation of well-characterized clinical specimen panels and direct comparisons with
established diagnostic assays.
In conclusion, virus enrichment via targeted amplification followed by NGS is an applicable
method for the diagnosis of VHFs which can be adapted for high-throughput or nanopore
sequencing platforms and employed for surveillance or outbreak monitoring.
Supporting information
S1 Table. Sequence of the primers included in the custom multiplex pool.
(XLS)




We kindly thank Ines Müller for contribution to PGM sequencing, Ursula Erikli for copy-edit-
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